BioNxt Solutions Inc. (OTCMKTS:BNXTF – Get Free Report) was the target of a large growth in short interest in the month of November. As of November 15th, there was short interest totalling 1,600 shares, a growth of 60.0% from the October 31st total of 1,000 shares. Based on an average daily trading volume, of 8,300 shares, the days-to-cover ratio is presently 0.2 days.
BioNxt Solutions Price Performance
Shares of BNXTF stock opened at $0.19 on Friday. The company’s 50 day moving average is $0.18 and its 200 day moving average is $0.20. BioNxt Solutions has a 52-week low of $0.11 and a 52-week high of $0.57.
BioNxt Solutions (OTCMKTS:BNXTF – Get Free Report) last released its quarterly earnings results on Wednesday, August 28th. The company reported ($0.01) EPS for the quarter.
About BioNxt Solutions
BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.
Read More
- Five stocks we like better than BioNxt Solutions
- Dividend Capture Strategy: What You Need to Know
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- Stock Analyst Ratings and Canadian Analyst Ratings
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Receive News & Ratings for BioNxt Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNxt Solutions and related companies with MarketBeat.com's FREE daily email newsletter.